Literature DB >> 29026590

Eosinophilic esophagitis: What can we learn from Crohn's disease?

Javier Molina-Infante1, Alain M Schoepfer2, Alfredo J Lucendo3, Evan S Dellon4.   

Abstract

Eosinophilic esophagitis (EoE) is an emerging esophageal inflammatory disorder affecting children and young adults. As a relatively new disease, EoE is still burdened by frequent diagnostic and therapeutic pitfalls in clinical practice. This manuscript posits a number of similarities with Crohn's disease, which may help optimize EoE patient management. Commonalities include epidemiologic trends (Westernized diseases, rising incidence, early-life risk factors), diagnostic considerations (symptoms are poor predictors of disease activity, difficulties in disease activity assessment) and therapeutic issues (similar natural history and therapeutic goals, induction and maintenance phases, combination of drug and endoscopic treatment, potential drug interchangeability, long-term unsolved issues). Physicians devoted to EoE should learn from the extraordinary achievements fulfilled in Crohn's disease: increased disease awareness, multidisciplinary specialized clinics, structured childhood and transition programs, and an ongoing roadmap for personalized treatments, including genetic susceptibility, risk factors for progression, genotype-phenotype correlation, drug monitoring and microbial data.

Entities:  

Keywords:  Crohn’s disease; Eosinophilic esophagitis; inflammatory bowel disease

Year:  2016        PMID: 29026590      PMCID: PMC5625864          DOI: 10.1177/2050640616672953

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  84 in total

1.  Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: Safety, Efficacy, and Persistence of the Fibrostenotic Phenotype.

Authors:  Thomas M Runge; Swathi Eluri; Cary C Cotton; Caitlin M Burk; John T Woosley; Nicholas J Shaheen; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2016-01-12       Impact factor: 10.864

Review 2.  Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease.

Authors:  Guillaume Pineton de Chambrun; Pierre Blanc; Laurent Peyrin-Biroulet
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-04-18       Impact factor: 3.869

3.  The ringed esophagus: histological features of GERD.

Authors:  J B Morrow; J J Vargo; J R Goldblum; J E Richter
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

Review 4.  Diagnosis and management of functional symptoms in inflammatory bowel disease in remission.

Authors:  Carlos Teruel; Elena Garrido; Francisco Mesonero
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 5.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

Review 6.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

Authors:  Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2007-08-08       Impact factor: 22.682

7.  Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study.

Authors:  B Giriens; P Yan; E Safroneeva; M Zwahlen; A Reinhard; A Nydegger; S Vavricka; C Sempoux; A Straumann; A M Schoepfer
Journal:  Allergy       Date:  2015-09-13       Impact factor: 13.146

Review 8.  Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis.

Authors:  Ryan Ungaro; Charles N Bernstein; Richard Gearry; Anders Hviid; Kaija-Leena Kolho; Matthew P Kronman; Souradet Shaw; Herbert Van Kruiningen; Jean-Frédéric Colombel; Ashish Atreja
Journal:  Am J Gastroenterol       Date:  2014-09-16       Impact factor: 10.864

9.  Risk of Autoimmunity in EoE and Families: A Population-Based Cohort Study.

Authors:  Kathryn Peterson; Rafael Firszt; John Fang; Jathine Wong; Ken R Smith; Kristina A Brady
Journal:  Am J Gastroenterol       Date:  2016-05-24       Impact factor: 10.864

10.  The Challenges of Living with Inflammatory Bowel Disease: Summary of a Summit on Patient and Healthcare Provider Perspectives.

Authors:  Judith Bray; Aida Fernandes; Geoffrey C Nguyen; Anthony R Otley; Joan Heatherington; Jennifer Stretton; Natasha Bollegala; Eric I Benchimol
Journal:  Can J Gastroenterol Hepatol       Date:  2016-02-22
View more
  8 in total

Review 1.  A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis.

Authors:  Evan S Dellon; Sandeep K Gupta
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-30       Impact factor: 11.382

Review 2.  Mechanisms and clinical management of eosinophilic oesophagitis: an overview.

Authors:  Luc Biedermann; Alex Straumann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-17       Impact factor: 73.082

Review 3.  Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.

Authors:  Mery Munoz-Persy; Alfredo J Lucendo
Journal:  Eur J Pediatr       Date:  2018-03-17       Impact factor: 3.183

4.  Increased Prevalence of Esophageal Eosinophilia in Patients with Inflammatory Bowel Disease.

Authors:  Y Claire Fan; David Steele; Bharati Kochar; Diana Arsene; Millie D Long; Evan S Dellon
Journal:  Inflamm Intest Dis       Date:  2019-03-20

5.  Comorbid Diagnosis of Eosinophilic Esophagitis and Inflammatory Bowel Disease in the Pediatric Population.

Authors:  Hillary Moore; Joshua Wechsler; Carrie Frost; Elizabeth Whiteside; Robert Baldassano; Jonathan Markowitz; Amanda B Muir
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-03-01       Impact factor: 3.288

Review 6.  Diagnostic and Therapeutic Long-term Management of Eosinophilic Esophagitis- Current Concepts and Perspectives for Steroid Use.

Authors:  Thomas Greuter; Jeffrey A Alexander; Alex Straumann; David A Katzka
Journal:  Clin Transl Gastroenterol       Date:  2018-12       Impact factor: 4.488

7.  Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS).

Authors:  Ekaterina Safroneeva; Catherine Saner; Jean-Benoît Rossel; Delphine Golay; Valérie Pittet; Sébastien Godat; Stefan Diem; Patrick Aepli; Mikael Sawatzki; Jan Borovicka; Konstantin Burgmann; Pascal Juillerat; Peter Netzer; Alexander Sendensky; Petr Hruz; Marc Girardin; Luc Biedermann; Thomas Greuter; Stephan Vavricka; Pierre Michetti; Christoph Mueller; Alex Straumann; Alain M Schoepfer
Journal:  Inflamm Intest Dis       Date:  2018-01-31

8.  Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic Esophagitis.

Authors:  Michael J Mintz; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2021-03-15       Impact factor: 5.325

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.